| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 52.3× | 28.0× | |
| Price / Book | 10.7× | 4.1× | |
| Price / Sales | 7.0× | 2.8× | |
| Price / Free cash flow | −91.0× | −9.6× | |
| EV / EBITDA | 30.2× | 21.3× | |
| Earnings yield | 1.9% | 2.1% | |
| Free cash flow yield | −1.1% | −3.4% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹639.95 | −1.01% | $11.81B | 227.7× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,486.70 | −1.45% | $2.63B | 101.4× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,434.80 | −8.87% | $1.91B | 125.0× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,010.00 | +0.30% | $1.29B | 66.1× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,238.60 | −3.20% | $863.07M | 84.9× | 11.9% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.62 | −0.38% | $318.26M | 137.4× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,438.40 | −2.66% | $256.63M | 74.9× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹483.00 | −0.88% | $226.08M | 150.9× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,719.60 | −3.56% | $207.66M | 47.6× | 16.9% | −5.3% |
VONSE:VOEPLVirtuoso OptoElectronics Ltd · 🇮🇳 NSE | ₹513.00 | +0.39% | $183.57M | 116.3× | 3.6% | — |
